characterized Sup35p from a spectrum of SaccharomyAmyloids are ␤ sheet rich, ordered structures consisting cetales (budding yeasts). Interestingly, we find that the of protofibrils (Sunde and Blake, 1997) that coalesce in ability to support a prion mechanism of inheritance is vitro to form extended fibrils that bind the dye Congo broadly conserved. Moreover, as with mammalian prired. Fibrils are also found under some conditions in vivo, ons, a species barrier prevents cross-species prion inalthough their role in pathogenesis remains unresolved duction. We have taken advantage of these phenomena (Lansbury, 1999). Despite having similar aggregated to elucidate the requirements for prion formation and structures, sequence comparison of amyloidogenic prothe molecular basis of this species barrier. teins fails to reveal any obvious similarities.
Amyloid protein aggregates have been increasingly im-
To investigate the requirements for prion formation plicated in human diseases, including prion-based enand amyloid specificity and to examine if there is evolucephalopathies, noninfectious neurodegenerative distionary pressure to retain prion function, we cloned and eases, and systemic amyloidoses (Koo et al., 1999) . characterized Sup35p from a spectrum of SaccharomyAmyloids are ␤ sheet rich, ordered structures consisting cetales (budding yeasts). Interestingly, we find that the of protofibrils (Sunde and Blake, 1997) that coalesce in ability to support a prion mechanism of inheritance is vitro to form extended fibrils that bind the dye Congo broadly conserved. Moreover, as with mammalian prired. Fibrils are also found under some conditions in vivo, ons, a species barrier prevents cross-species prion inalthough their role in pathogenesis remains unresolved duction. We have taken advantage of these phenomena . Despite having similar aggregated to elucidate the requirements for prion formation and structures, sequence comparison of amyloidogenic prothe molecular basis of this species barrier. teins fails to reveal any obvious similarities.
A striking property of most amyloids is the ability to catalyze their own propagation. In prion diseases, this Results self-propagation is thought to be the basis of proteinmediated infectivity. Here, the abnormal ␤ sheet-rich
The Prion Domain Is Conserved in Yeast Evolution
The N terminus of Sup35p is necessary and sufficient prion form (PrP (Figure 2A ). In conaggregates to "infect" the maintainer PrD is monitored by the permanent change in suppression phenotype. trast, expression of fusion proteins containing PrDMs Figure 5B ). Immunoelectron microscopy confirmed that these two prions had a strong preference to form amyloid fibrils composed of a single species. We used a speciesspecific polyclonal antibody to label S. cerevisiae PrDM with 5 nm gold particles and a monoclonal epitope tag- We created two complementary chimeric proPrDM SC from denaturant, there is an initial lag phase of ‫021ف‬ minutes, followed by a cooperative conversion teins, the first of which (PrDM SC1-39CA ) contained residues 1 to 39 from S. cerevisiae with the remaining PrD sefrom random coil to ␤ sheet-rich amyloid fibrils. This conversion can be readily monitored by selective bindquence from C. albicans, and the second (PrDM CA1-39SC ) in which the first 39 residues of PrDM SC were replaced ing of the fibrils to the dye Congo red ( Figure 4A ). Importantly, the addition of preformed fibril catalyzes this conwith the C. albicans sequence ( Figure 6A ). Microscopic examination of GFP fusions shows that both chimeras version by eliminating the lag phase, thus recapitulating in vitro the self-propagation of the prion state.
form aggregates ( Figure 6C and data Figure 4B) . Strikingly, the addition of PrDM CA fibrils, even at amounts that could efficiently is sufficient to allow crossing of the species barrier, we constructed a third chimera consisting of residues 8 catalyze PrDM CA amyloid formation, did not convert PrDM SC ( Figure 4A) . Conversely, addition of PrDM SC seed to 26 of S. cerevisiae replacing the corresponding C. albicans sequence, denoted PrD SC8-26CA ( Figure 6A ). This did not alter the kinetics of PrDM CA fibril formation (Figure 4B) . Thus, our in vitro seeding experiments mirror a chimeric PrDM-GFP retains the ability to aggregate and is seeded by the endogenous Sup35p aggregate, as key aspect of the in vivo homotypic conversion experiments, in which prion formation is initiated only by hoshown by the visual assay ( Figure 6C Figure 6B ). These data indicate that a of a fibril seed failed to convert PrDM from another short peptide epitope composed of residues 8 to 26, presumably on the growing face of the amyloid, is sufficient to mediate specificity in the incorporation of monomers into the polymerizing fibril ( Figure 6D , see Discussion).
Identification of a Novel Prion-Forming Protein in S. cerevisiae
The observation that all known yeast prion proteins have high Gln/Asn content and few charged residues ( Figure  1B) suggests that proteins with similar properties could form prions. A search of genomic databases revealed that several other proteins have domains with similar properties (Figure 7A and M. Michelitsch and J. S. W., unpublished data). We experimentally examined the ability of one such domain from a protein encoded by the uncharacterized ORF YPL226W (NEW1) to form a prion using the two-plasmid assay described above. Figure  7C ). Taken together, these observations argue the Gln/ Asn-rich N-terminal region of New1p can support a prion mechanism of inheritance.
Discussion
To investigate how prions can specifically propagate in the complex cellular milieu, we have cloned and characterized the N-terminal prion domain (PrD) from a range of budding yeasts. Despite the long evolutionary distances separating these species (Kurtzman, 1994) analyses, however, suggest that species-dependent interactions between the prion particles and an unidentiered as differences in pathology between isolates of scrapie, mammalian prion strains were thought to result fied host factor, termed Protein X, also contribute subfrom nucleic acid variations, arguing against a proteinstantially to the species barrier (Telling et al., 1995) . mediated mechanism of prion infectivity. It now appears
These issues have been difficult to resolve because of that the presence of stable, distinct strains, possibly the inability thus far either to produce de novo infectious arising from different prion conformations, is an inherent PrP SC or to effectively recapitulate sustained prion propproperty of prions. agation in vitro. Our data show that for the yeast [PSI ϩ ] prion, the species barrier results from a remarkable specificity in Insights into the Molecular Architecture of the Prion Domain: Specificity and Stability Domains interaction between the prion protein itself, mediated by a well-defined epitope in the PrD ( Figure 6D ). First, within the PrD The mammalian prion species barrier, which prevents for all of the species examined, only overexpression of homotypic PrD induces prion formation. Similarly, the spread of scrapie and bovine spongiform encephalopathy to man, has been the focus of intense research Chernoff and coworkers have recently found that the C. albicans induces formation of punctate foci, although it remains to be seen whether these aggregates can Liu and Lindquist, 1999). Moreover, expansion of the imperfect oligopeptide repeats, also located outside propagate in a prion-like manner (unpublished observations). of this species-determining domain, dramatically enhances the rate of prion formation. These observations, As a mechanism of inheritance, prions provide a number of potentially advantageous features (Lindquist, together with our in vitro selective seeding experiments, suggest a model ( Figure 6D ) in which the N terminus 1997). Prion formation allows a cell to inhibit the activity of a specific protein and propagate this state indefinitely resides on the surface of the growing amyloid and contributes much of the specificity of PrD monomer recruitwhile retaining the potential to restore the original protein activity. Moreover, the rate of conversion to and ment. By contrast, the more C-terminal region might largely be involved in intramolecular interactions that from the prion state can be dramatically enhanced by changes in the environment ( 
